Literature DB >> 7102362

Prevalence of intermittent claudication and its effect on mortality.

A Reunanen, H Takkunen, A Aromaa.   

Abstract

The prevalence of symptoms of intermittent claudication and their association with 5-year mortality were examined in a population study in Finland. A number of 5738 men and 5224 women, aged 30-59 years, from 4 geographic areas of the country were studied. According to a structured interview, 2.1% of the men and 1.8% of the women reported typical symptoms of intermittent claudication. Claudication was most prevalent in East Finland and among persons with agricultural occupations. The symptoms were more frequent in diabetics and persons with symptoms and signs of coronary heart disease (CHD) than in persons without these diseases. High serum cholesterol and smoking were associated with these symptoms but high blood pressure was not. The risk of death from cardiovascular causes was nearly 3-fold in men with claudication compared to men without claudication. Symptoms of chest pain and smoking increased significantly the mortality risk of male claudicants. The validity of symptoms was poorer in women than in men and they were also less reliable predictors of death in women. A small part of the effect of claudication on mortality was due to its association with conventional CHD risk factors. However, after adjusting for symptoms and signs of CHD, claudication had no independent effect on mortality in men.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7102362     DOI: 10.1111/j.0954-6820.1982.tb01939.x

Source DB:  PubMed          Journal:  Acta Med Scand        ISSN: 0001-6101


  21 in total

Review 1.  Beraprost: a review of its pharmacology and therapeutic efficacy in the treatment of peripheral arterial disease and pulmonary arterial hypertension.

Authors:  Ezequiel Balmori Melian; Karen L Goa
Journal:  Drugs       Date:  2002       Impact factor: 9.546

Review 2.  Current strategies in the diagnosis and management of lower extremity peripheral vascular disease.

Authors:  T J Wilt
Journal:  J Gen Intern Med       Date:  1992 Jan-Feb       Impact factor: 5.128

3.  Fate in intermittent claudication: outcome and risk factors.

Authors:  R Jelnes; O Gaardsting; K Hougaard Jensen; N Baekgaard; K H Tønnesen; T Schroeder
Journal:  Br Med J (Clin Res Ed)       Date:  1986-11-01

4.  Claudication.

Authors:  V C Ruckley
Journal:  Br Med J (Clin Res Ed)       Date:  1986-04-12

Review 5.  The prognosis of non-critical limb ischaemia: a systematic review of population-based evidence.

Authors:  J D Hooi; H E Stoffers; J A Knottnerus; J W van Ree
Journal:  Br J Gen Pract       Date:  1999-01       Impact factor: 5.386

Review 6.  Aetiology of peripheral atherosclerosis.

Authors:  F G Fowkes
Journal:  BMJ       Date:  1989-02-18

7.  Drug treatment of intermittent claudication: a critical analysis of the methods and findings of published clinical trials, 1965-1985.

Authors:  H A Cameron; P C Waller; L E Ramsay
Journal:  Br J Clin Pharmacol       Date:  1988-11       Impact factor: 4.335

8.  The reliability of differentiating neurogenic claudication from vascular claudication based on symptomatic presentation.

Authors:  Mélissa Nadeau; M Patricia Rosas-Arellano; Kevin R Gurr; Stewart I Bailey; David C Taylor; Ruby Grewal; D Kirk Lawlor; Chris S Bailey
Journal:  Can J Surg       Date:  2013-12       Impact factor: 2.089

9.  Drug treatment of peripheral arterial disease in the elderly.

Authors:  Wilbert S Aronow
Journal:  Drugs Aging       Date:  2006       Impact factor: 3.923

10.  Prevalence of peripheral arterial disease in high-risk patients using ankle-brachial index in general practice: a cross-sectional study.

Authors:  P Cacoub; J-P Cambou; S Kownator; J-P Belliard; J-P Beregi; A Branchereau; P Carpentier; P Léger; F Luizy; D Maïza; E Mihci; M-A Herrmann; P Priollet
Journal:  Int J Clin Pract       Date:  2009-01       Impact factor: 2.503

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.